Meiji Yasuda Asset Management Co Ltd. Acquires New Shares in Cigna Group $CI

Meiji Yasuda Asset Management Co Ltd. bought a new stake in Cigna Group (NYSE:CIFree Report) during the 2nd quarter, Holdings Channel reports. The fund bought 6,641 shares of the health services provider’s stock, valued at approximately $1,831,000.

Other institutional investors also recently modified their holdings of the company. Brighton Jones LLC increased its stake in Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after purchasing an additional 318 shares in the last quarter. Sivia Capital Partners LLC boosted its position in shares of Cigna Group by 10.4% during the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after purchasing an additional 109 shares in the last quarter. NewEdge Advisors LLC grew its holdings in shares of Cigna Group by 4.5% in the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after buying an additional 958 shares during the period. Treasurer of the State of North Carolina grew its holdings in shares of Cigna Group by 16.6% in the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after buying an additional 21,173 shares during the period. Finally, Osterweis Capital Management Inc. bought a new stake in shares of Cigna Group in the 2nd quarter valued at $163,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Stock Up 1.0%

Shares of CI stock opened at $280.32 on Tuesday. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The firm has a fifty day moving average of $283.92 and a 200-day moving average of $281.48. The company has a market capitalization of $74.07 billion, a price-to-earnings ratio of 11.60, a P/E/G ratio of 0.95 and a beta of 0.29.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating the consensus estimate of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities research analysts predict that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s payout ratio is 25.82%.

Insider Transactions at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Nicole S. Jones sold 2,677 shares of Cigna Group stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. This represents a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 23,012 shares of company stock worth $6,386,550. Corporate insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

CI has been the topic of several research analyst reports. Wells Fargo & Company raised their price objective on Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Cantor Fitzgerald boosted their target price on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Wall Street Zen downgraded Cigna Group from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Jefferies Financial Group lowered Cigna Group from a “buy” rating to a “hold” rating and dropped their price target for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. Finally, Royal Bank Of Canada lifted their price objective on Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a report on Friday, May 1st. Fifteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $339.45.

View Our Latest Analysis on CI

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.